1. Home
  2. VYGR vs ESCA Comparison

VYGR vs ESCA Comparison

Compare VYGR & ESCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ESCA
  • Stock Information
  • Founded
  • VYGR 2013
  • ESCA 1922
  • Country
  • VYGR United States
  • ESCA United States
  • Employees
  • VYGR N/A
  • ESCA N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ESCA Recreational Games/Products/Toys
  • Sector
  • VYGR Health Care
  • ESCA Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • ESCA Nasdaq
  • Market Cap
  • VYGR 165.5M
  • ESCA 209.5M
  • IPO Year
  • VYGR 2015
  • ESCA N/A
  • Fundamental
  • Price
  • VYGR $2.74
  • ESCA $14.84
  • Analyst Decision
  • VYGR Strong Buy
  • ESCA
  • Analyst Count
  • VYGR 8
  • ESCA 0
  • Target Price
  • VYGR $14.33
  • ESCA N/A
  • AVG Volume (30 Days)
  • VYGR 377.3K
  • ESCA 15.2K
  • Earning Date
  • VYGR 05-06-2025
  • ESCA 05-05-2025
  • Dividend Yield
  • VYGR N/A
  • ESCA 4.04%
  • EPS Growth
  • VYGR N/A
  • ESCA 9.37
  • EPS
  • VYGR N/A
  • ESCA 0.99
  • Revenue
  • VYGR $66,958,000.00
  • ESCA $249,685,000.00
  • Revenue This Year
  • VYGR N/A
  • ESCA N/A
  • Revenue Next Year
  • VYGR $45.34
  • ESCA N/A
  • P/E Ratio
  • VYGR N/A
  • ESCA $15.00
  • Revenue Growth
  • VYGR N/A
  • ESCA N/A
  • 52 Week Low
  • VYGR $2.65
  • ESCA $12.53
  • 52 Week High
  • VYGR $9.55
  • ESCA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 33.88
  • ESCA 49.25
  • Support Level
  • VYGR $2.71
  • ESCA $14.58
  • Resistance Level
  • VYGR $2.99
  • ESCA $16.04
  • Average True Range (ATR)
  • VYGR 0.18
  • ESCA 0.70
  • MACD
  • VYGR -0.05
  • ESCA -0.00
  • Stochastic Oscillator
  • VYGR 10.86
  • ESCA 51.22

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

Share on Social Networks: